Advertisement. Remove ads.
Super Group Stock Soars On Strong Q4 Revenue And Ebitda Outlook: Retail Sentiment Jumps
Shares of Super Group ($SGHC) soared 8% on Wednesday after the online sports betting company provided a strong update on its preliminary, unaudited fourth-quarter and full-year 2024 results, lifting retail sentiment.
According to a company statement, Q4 is expected to be its “strongest ever ex-US quarter” with total revenues of about €486 million (about $506 million). Its adjusted non GAAP earnings before interest, taxes, depreciation and amortization (Ebitda)is expected between €125 million and €130 million.
For the full-year, the company expects to have surpassed its previously issued ex-US guidance target of revenue of €1.60 billion and adjusted EBITDA of greater than €360 million.
It said its developing U.S. business should also deliver new records in Q4 for revenue, compared to previous months. The expected Q4 2024 investment into the U.S. business is about €11 million, for a total of €61 million.
“I’m proud to have ended 2024 on a high, with new records expected for both total revenue and adjusted EBITDA. This momentum has continued into the start of 2025, setting a solid foundation for the year ahead,” Neal Menashe, Super Group's CEO said.
Sentiment on Stocktwits jumped to ‘extremely bullish’ from ‘neutral.’ Message volumes increased to ‘extremely high’ from ‘low.’
Commenters on the Stocktwits platform were optimistic about the company’s fundamentals and price movement.
/filters:format(webp)/images/default_avatar_6_large.png){kind=avatar}
While another user was thrilled about the cash flow and Ebitda guidance.
Super Group operates several online sports betting and gaming businesses. Its brands include Betway, which focuses on online sports betting; and Spin, a multi-brand online casino/
Super Group stock is up 8% year-to-date
For updates and corrections, email newsroom[at]stocktwits[dot]com.
1 EUR = 1.04 USD
Latest News
/filters:format(webp)https://news.stocktwits-cdn.com/large_office_depot_OG_jpg_600537d787.webp)
/filters:format(webp)https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Prabhjote_DP_67623a9828.jpg)
Prabhjote Gill·11h ago/filters:format(webp)https://news.stocktwits-cdn.com/large_trump_tiktok_OG_jpg_bfedb9a55c.webp)
Prabhjote Gill·8h ago/filters:format(webp)https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/large_applied_digital_logo_resized_4885381f60.jpg){kind=logo}
/filters:format(webp)https://news.stocktwits-cdn.com/shivani_photo_jpg_dd6e01afa4.webp)
Shivani Kumaresan·4h ago/filters:format(webp)https://news.stocktwits-cdn.com/large_trump_bitcoin_OG_jpg_056cff9877.webp)
Prabhjote Gill·8h ago/filters:format(webp)https://news.stocktwits-cdn.com/large_Getty_Images_2233528749_jpg_bf85391f87.webp)
/filters:format(webp)https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/unnamed_jpg_9dff551b50.webp)
Anan Ashraf·4h ago/filters:format(webp)https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/large_sealsq_stock_market_representative_resized_b05435011f.jpg)
Anan Ashraf·10h agoCelsius Stock Slips On Analyst Downgrade Amid Rising Competition: Retail Mood Dampens
Shares of Celsius Holdings (CELH) slipped more than 5% on Wednesday after brokerage firm TD Cowen downgraded its stock to ‘hold’ from ‘buy,’ dampening retail sentiment.
TD Cowen also cut its price target to $29 from $40, Fly.com reported. According to the report, TD Cowen’s retail tracking data showed a decline in the company's sales growth to 0.3% in the last four weeks ending January 11.
With Celsius shares well below its highs, valuation multiples could contract further if the company goes "ex-growth," said the report, citing the analyst who warned against heightened competition.
Morgan Stanley also highlighted NielsenIQ data that showed Celsius' year-over-year sales dipped in the last two weeks that were assessed, showing a 6% decline in the latest week.
Morgan Stanley has kept its ‘Equal Weight’ rating and $42 price target.
Sentiment on Stocktwits turned ‘bearish’ from ‘bullish’ a week ago. Message volumes rose to ‘extremely high’ levels from ‘normal.’
Last week, UBS analyst Peter Grom also cut the firm's price target to $39 from $45 with a ‘Buy’ rating, Fly.com reported. According to the analyst, sentiment about consumer staples continues to be bearish despite the sector underperformance compared to the broader market in recent years, with top and bottom line growth for majority of the group has underwhelmed compared to expectations.
Celsius is a maker of premium lifestyle energy drinks under its namesake 'Celsisus' brand.
Celsius stock is down 3.7% year-to-date.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
C3.ai Stock Rises On Broader AI Optimism, McKinsey Partnership: Retail Sentiment Rebounds
C3.ai, Inc. (AI) stock rose on Wednesday as traders reacted positively to the company’s new partnership and the Trump administration’s AI-focused announcements.
The Redwood City, California-based enterprise AI software applications company has forged a strategic alliance with management consultancy firm McKinsey & Co. to help clients and prospects accelerate AI transformation at scale.
The companies said the alliance looks to leverage McKinsey’s AI practice, QuantumBlack, and its track record of deploying and scaling AI solutions across industries with c3.ai’s enterprise AI software application.
Thomas Siebel, Chairman and CEO of c3.ai, said, "Organizations that choose to partner with us can have confidence in ROI with a focus on managing risk. This is how you win with AI."
According to the companies, the alliance will be global in scale, serving clients worldwide.
The c3.ai stock rally could also be traced back to abounding broader optimism toward AI stocks amid a series of initiatives from Donald Trump.
Shortly after rescinding AI regulations put in place by his predecessor Joe Biden, the president announced a private industry collaboration, spearheaded by OpenAI, that envisages a $500 billion investment to build AI infrastructure across the country.
The latest announcement set in motion substantial gains in stocks of companies involved in the collaboration, such as Arm Holdings plc. (ARM), Oracle Corp. (ORCL) and Nvidia Corp. (NVDA), as well as other stocks with exposure to the technology.
On Stocktwits, sentiment toward c3.ai improved to ‘extremely bullish’ (89/100), flipping from the ‘bearish’ mood that prevailed a day ago. Message volume has spurted to ‘extremely high' levels.
A watcher of the stock on the platform said c3.ai will potentially receive fresh investment under the new Stargate joint venture announced by Trump.
/filters:format(webp)/production/1330984/large-1657216051.png)
$AI stock are seeing fresh investment through recent announcement last night. Mind you all these are software based investment.
This is how it playout.
Day 1 market will try to short it.
Day 2 Market realized its trend
Day 3 Market will jump on it
Similar as any long term trend
$ASST 
$POAI $CRNC BullishAnother said $50 stock price could be in play amid the developments.
/filters:format(webp)/production/5090217/large-1625425069.png)
$AI fifty in the window! Bullishc3.ai stock was up nearly 5% to $34.41 at last check.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype
Shares of Recursion Pharmaceuticals Inc climbed 5.6% on Wednesday morning, reaching a three-week high as trading volumes hit 1.4 times the daily average.
The stock is on track for its third consecutive session of gains, which would mark its best streak in over two weeks.
While no specific catalyst directly triggered the surge, the buzz likely stems from broader developments in artificial intelligence.
President Donald Trump's announcement of "Stargate," a multibillion-dollar AI joint venture led by OpenAI, on Wednesday drove a rally in high-profile AI stocks, including Nvidia.
The connection to Recursion? The company is a clinical-stage biotech innovator leveraging automation, artificial intelligence, machine learning, and in vivo validation to discover new medicines.
Nvidia's $50 million investment in Recursion, unveiled in 2023 to support AI-driven drug discovery, has been a key driver of investor interest.
That remained the case on Stocktwits on Wednesday, where sentiment for Recursion turned "extremely bullish" as message volume surged, placing the ticker among the platform's top 10 trending symbols.
/filters:format(webp)/production/8180698/large-1717341309.png)
/filters:format(webp)/production/9078339/large-1752265594.png)
/filters:format(webp)/production/1332756/large-1519434122.png)
The company's AI-driven drug discovery platform and diverse pipeline include six programs (including oncology drugs), some of which are in Phase 2 trials.
Despite a significant retail following, Recursion's stock has faced challenges. According to Koyfin data, short interest stands at 18.7%.
Over the past year, the company's Stocktwits followers have tripled, and message volume has jumped more than 500%, even as the stock has lost more than 32% in the same period.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
DigitalOcean Stock Rises On Launch Of New Generative AI Platform: Retail Turns Bullish
Shares of DigitalOcean Holdings Inc. (DOCN) gained more than 2% in mid-day trade on Wednesday after the company launched a new generative AI platform.
DigitialOcean made the announcement at Deploy 25, its annual developer conference. The company’s new generative AI platform allows customers to use foundational models from third-party providers.
This allows users to make use of multiple large language models without being locked into a single platform.
“As AI continues to enhance business strategies, it is essential to have a partner like us that is evolving with technology and making AI accessible for users,” said Bratin Saha, Chief Product and Technology Officer at DigitalOcean.
DigitalOcean said its generative AI solution works with both structured and unstructured data. Users can fine-tune their prompts to filter out unwanted or incorrect results and create AI agents based on their requirements.
“Generative AI is an evolving concept, but our team has worked tirelessly to create an easy-to-use platform that seamlessly integrates with our customers' existing infrastructure and has a low barrier to entry for developers at any expertise level,” Saha added.
Retail sentiment on Stocktwits moved in sync with the DigitalOcean stock price, entering the ‘bullish’ (65/100) territory from ‘bearish’ a day ago. Message volume was also in the ‘high’ zone at the time of writing.
Meanwhile, one user thinks the DigitialOcean stock could cross the $40 mark as it enters earnings season.
/filters:format(webp)/images/default_avatar_14_large.png){kind=avatar}
$DOCNAnalysts at Morgan Stanley upgraded DigitalOcean to ‘Overweight’ from ‘Equal Weight’ last week, with a price target of $41.
Cantor Fitzgerald analysts have assigned the stock a ‘Neutral’ rating and a price target of $39.
DigitalOcean’s share price has surged more than 18% over the past six months, but its one-year performance is relatively less stellar, with gains of 9.5%.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Also See: Celestica Stock Surges As Board Member Steps Down Ahead Of Earnings: Retail Turns Extremely Bullish
Agilysys Stock Eyes 3-Month Lows After Sinking 20% Premarket On Mixed Q3 Results, Guidance Cut: Retail Mood Nosedives
Agilysys, Inc. (AGYS) stock plummeted in Wednesday’s premarket after the Alpharetta, Georgia-based provider of hospitality industry-focused software-enabled solutions and services reported mixed quarterly results and cut its guidance.
The company reported fiscal 2025 third-quarter adjusted earnings per share (EPS) of $0.38, higher than the $0.35 for the year-ago quarter and the consensus of $0.34, according to Koyfin.
Net revenue climbed nearly 15% year-over-year (YoY) to a record $69.6 million, and yet missed the $74.15 consensus. Agilysys noted that recurring revenue, comprising subscription and maintenance charges, was at a record $44.4 million and accounted for nearly 64% of the total revenue.
Gross margin expanded YoY to 63% from 62.5%.
Ramesh Srinivasan, CEO of Agilysys, said, “Subscription revenue continues to grow at a healthy pace and we are pleased with the integration progress of the Book4Time acquisition.”
“However, revenue levels, especially one-time product revenue, continue to be impacted by recent sales challenges with point-of-sale products, mainly in the managed food services vertical, caused by our final modernization transition phase.”
Agilysys also sounded a note of caution regarding its forward outlook. It expects fiscal year 2025 product revenue, including hardware revenue, to remain challenged. However, it expects the year to be a good one for subscription revenue, which is expected to grow at least 38%.
As such, the company cut its annual revenue outlook to $273 million from the previously issued $280 million to $285 million range. The company maintained its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) margin outlook of 18%.
On Stocktwits, sentiment toward Agilysys stock plummed to ‘extremely bearish’ (3/100), the lowest level in over a year, from the ‘neutral’ mood that prevailed a day ago. Message volume is at ‘extremely high’ levels.
A retail stock watcher said the stock is entering a bearish trend.
Another said the stock was overpriced based on several factors and recommended shorting the stock.
/filters:format(webp)/production/5927876/large-1701146598.png)
In premarket trading, Agilysys stock slumped 20.18% to $100.49. If the decline persists until the market opens, the stock will hit a three-month low. The stock is likely to suffer its biggest one-loss since Oct. 2023.
For updates and corrections, email newsroom[at]stocktwits[dot]com.